These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1420478)

  • 1. Spectrophotometric determination of famotidine in pharmaceutical preparations.
    Agrawal YK; Shivramchandra K; Singh GN; Rao BE
    J Pharm Biomed Anal; 1992 Jul; 10(7):521-3. PubMed ID: 1420478
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic spectrophotometric determination of famotidine in commercial dosage forms.
    Rahman N; Kashif M
    Anal Sci; 2003 Jun; 19(6):907-11. PubMed ID: 12834233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate Validated Models for Simultaneous Determination of Ibuprofen and Famotidine in the Presence of Related Substances.
    Elzanfaly ES; Zaazaa HE; Soudi AT; Salem MY
    J AOAC Int; 2018 Jul; 101(4):1001-1007. PubMed ID: 28874228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrophotometric determination of three anti-ulcer drugs through charge-transfer complexation.
    Al-Ghannam S; Belal F
    J AOAC Int; 2002; 85(5):1003-8. PubMed ID: 12374395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New colorimetric methods for the determination of trazodone HCl, famotidine, and diltiazem HCl in their pharmaceutical dosage forms.
    Ayad MM; Shalaby A; Abdellatef HE; Hosny MM
    Anal Bioanal Chem; 2003 Jul; 376(5):710-4. PubMed ID: 12750873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of famotidine through charge-transfer complexation with chloranilic acid.
    Chukwurah BK; Ajali U
    Boll Chim Farm; 2001; 140(5):354-60. PubMed ID: 11680091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the ratio difference spectrophotometry to the determination of ibuprofen and famotidine in their combined dosage form: comparison with previously published spectrophotometric methods.
    Zaazaa HE; Elzanfaly ES; Soudi AT; Salem MY
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 143():251-5. PubMed ID: 25733252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of ninhydrin to spectrophotometric determination of famotidine in drug formulations.
    Rahman N; Kashif M
    Farmaco; 2003 Oct; 58(10):1045-50. PubMed ID: 14505737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [UV spectrophotometric assay of famotidine in combination with picrolonic acid, picrolinate].
    Apostu M; Bibire N; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):422-5. PubMed ID: 16607813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extractional-spectrophotometric determination of famotidine in pharmaceutical formulations.
    Abu Zuhri AZ; Shubietah RM; Badah GM
    J Pharm Biomed Anal; 1999 Nov; 21(2):459-65. PubMed ID: 10704003
    [No Abstract]   [Full Text] [Related]  

  • 11. Derivative emission spectrofluorimetry: Application to the analysis of newly approved FDA combination of ibuprofen and famotidine in tablets.
    Ragab MA; El-Kimary EI
    Luminescence; 2015 Sep; 30(6):760-7. PubMed ID: 25421838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiometric determination of famotidine in pharmaceutical formulations.
    Ayad MM; Shalaby A; Abdellatef HE; Elsaid HM
    J Pharm Biomed Anal; 2002 Jun; 29(1-2):247-54. PubMed ID: 12062684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a method for the assay of related compounds in famotidine raw materials and formulations.
    Beaulieu N; Graham SJ; Sears RW; Lovering EG
    J Pharm Biomed Anal; 1989; 7(12):1705-9. PubMed ID: 2490558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticals.
    Helali N; Tran NT; Monser L; Taverna M
    Talanta; 2008 Jan; 74(4):694-8. PubMed ID: 18371695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of cyproterone acetate and ethinylestradiol in tablets by derivative spectrophotometry.
    Souri E; Jalalizadeh H; Farsam H; Ghadiri R; Amanlou M
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):949-51. PubMed ID: 16079526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrofluorimetric analysis of famotidine in pharmaceutical preparations and biological fluids by derivatization with benzoin.
    Alamgir M; Khuhawar MY; Memon SQ; Hayat A; Zounr RA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 134():449-52. PubMed ID: 25033237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization and validation of a dissolution test for famotidine tablets using flow injection analysis.
    Tzanavaras PD; Verdoukas A; Balloma T
    J Pharm Biomed Anal; 2006 May; 41(2):437-41. PubMed ID: 16413732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis.
    Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
    Electrophoresis; 2001 Aug; 22(13):2758-62. PubMed ID: 11545404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of ambroxol in tablets by derivative UV spectrophotometric method and HPLC.
    Dinçer Z; Basan H; Göger NG
    J Pharm Biomed Anal; 2003 Apr; 31(5):867-72. PubMed ID: 12684099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of diclofenac sodium, famotidine and ketorolac tromethamine by flow injection analysis using dichloronitrophenol.
    Kamath BV; Shivram K; Shah AC
    J Pharm Biomed Anal; 1994 Mar; 12(3):343-6. PubMed ID: 8031933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.